Tech Company Financing Transactions

Aerpio Pharmaceuticals Funding Round

Aerpio Pharmaceuticals closed a $9 million Series A funding round on 11/6/2013. Investors included Satter Investment Management, Athenian Venture Partners and Kearny Venture Partners.

Transaction Overview

Company Name
Aerpio Pharmaceuticals
Announced On
11/6/2013
Transaction Type
Venture Equity
Amount
$9,000,000
Round
Series A
Investors

Satter Investment Management (Lead Investor) (Muneer Satter )

Athenian Venture Partners (Daniel Kosoy)

Kearny Venture Partners (Anupam Dalal)

Novartis BioVenture Fund (Campbell Murray)

Triathlon Medical Ventures

Venture Investors (Paul Weiss)

Proceeds Purpose
The additional funding that is now in hand allows us to expand the clinical program for AKB-9778, including greater flexibility in our trial design to obtain proof of concept, both as a monotherapy and as an adjunct with a VEGF inhibitor, in the treatment of DME.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9987 Carver Rd. 420
Cincinnati, OH 45242
USA
Phone
(513) 985-1920
Website
www.aerpio.com
Email Address
[email protected]
Overview
Aerpio Pharmaceuticals, a biopharmaceutical company,develops first-in-class treatments for ocular diseases.
Profile
Aerpio Pharmaceuticals LinkedIn Company Profile
Social Media
Aerpio Pharmaceuticals Company Twitter Account
Company News
Aerpio Pharmaceuticals News
Facebook
Aerpio Pharmaceuticals on Facebook
YouTube
Aerpio Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Stephen Hoffman
  Stephen Hoffman LinkedIn Profile  Stephen Hoffman Twitter Account  Stephen Hoffman News  Stephen Hoffman on Facebook
Chief Financial Officer
Michael Rogers
  Michael Rogers LinkedIn Profile  Michael Rogers Twitter Account  Michael Rogers News  Michael Rogers on Facebook
Chief Medical Officer
Steve Pakola
  Steve Pakola LinkedIn Profile  Steve Pakola Twitter Account  Steve Pakola News  Steve Pakola on Facebook
Chief Scientific Officer
Kevin Peters
  Kevin Peters LinkedIn Profile  Kevin Peters Twitter Account  Kevin Peters News  Kevin Peters on Facebook
President
Joseph Gardner
  Joseph Gardner LinkedIn Profile  Joseph Gardner Twitter Account  Joseph Gardner News  Joseph Gardner on Facebook
Vice President
Brandi Soldo
  Brandi Soldo LinkedIn Profile  Brandi Soldo Twitter Account  Brandi Soldo News  Brandi Soldo on Facebook
VP - Bus. Development
Mitchell Brigell
  Mitchell Brigell LinkedIn Profile  Mitchell Brigell Twitter Account  Mitchell Brigell News  Mitchell Brigell on Facebook
VP - Finance
Gina Marek
  Gina Marek LinkedIn Profile  Gina Marek Twitter Account  Gina Marek News  Gina Marek on Facebook

 

 

Browse more venture capital transactions:

Prev: 11/6/2013: M5 Labs venture capital transaction
Next: 11/6/2013: Degreed venture capital transaction

 

Share this article

 

News on VC Transactions

We do our best to document funding rounds that are announced publicly. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.